The updated 2026 revenue guidance assumes a more measured and prolonged recovery, with market-related headwinds expected to ...

CFO Francisco noted, "Our 2026 total revenue guidance now reflects the expectation that we see more measured improvement in clinician confusion and the overall operating environment as we move through ...

Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year revenue decline in the first quarter of 2026, with executives ...

Guidance language tightened: Q4 2025 guided to "total net revenue" decline of "25% to 38%" (Chief Financial Officer Francisco, Q4 2025), while Q1 2026 updated to "$270 million to $310 million" and "a ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of ...

Detailed price information for Organogenesis Holdings Inc (ORGO-Q) from The Globe and Mail including charting and trades.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Medicare's new reimbursement ...

Organogenesis received confirmation to initiate a license application with the Food and Drug Administration for its knee condition treatment ReNu. The regenerative tissue company said Monday it plans ...

Organogenesis Holdings (NASDAQ:ORGO) reported its financial results for Q1 2025, revealing a significant decline in revenue and an unexpected operating loss. The company’s stock took a sharp downturn ...

CANTON, Mass. - Organogenesis Holdings Inc. (NASDAQ:ORGO) saw its shares jump 12.4% after the regenerative medicine company reported fourth-quarter results that exceeded analyst expectations and ...

Organoid culture has emerged as a forefront technology in the life sciences field. As “in vitro micro-organs”, organoids can faithfully recapitulate the organogenesis process, and conserve the key ...

Organogenesis (ORGO) Holdings announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way ...